24 related articles for article (PubMed ID: 1472063)
1. Proinsulin C-peptide and insulin: Limited pattern similarities of interest in inter-peptide interactions but no C-peptide effect on insulin and IGF-1 receptor signaling.
Henriksson M; Johansson J; Moede T; Leibiger I; Shafqat J; Berggren PO; Jörnvall H
Cell Mol Life Sci; 2006 Dec; 63(24):3055-60. PubMed ID: 17115117
[TBL] [Abstract][Full Text] [Related]
2. Coordinated regulation of insulin signaling by the protein tyrosine phosphatases PTP1B and TCPTP.
Galic S; Hauser C; Kahn BB; Haj FG; Neel BG; Tonks NK; Tiganis T
Mol Cell Biol; 2005 Jan; 25(2):819-29. PubMed ID: 15632081
[TBL] [Abstract][Full Text] [Related]
3. Signal transduction by a chimeric insulin-like growth factor-1 (IGF-1) receptor having the carboxyl-terminal domain of the insulin receptor.
Tartare S; Mothe I; Kowalski-Chauvel A; Breittmayer JP; Ballotti R; Van Obberghen E
J Biol Chem; 1994 Apr; 269(15):11449-55. PubMed ID: 8157675
[TBL] [Abstract][Full Text] [Related]
4. Differential phosphorylation of pp120 by insulin and insulin-like growth factor-1 receptors: role for the C-terminal domain of the beta-subunit.
Najjar SM; Blakesley VA; Li Calzi S; Kato H; LeRoith D; Choice CV
Biochemistry; 1997 Jun; 36(22):6827-34. PubMed ID: 9184166
[TBL] [Abstract][Full Text] [Related]
5. NIH 3T3 cells transfected with a yeast H(+)-ATPase have altered sensitivity to insulin, insulin growth factor-I, and platelet-derived growth factor-AA.
Peterson EP; Martinez GM; Martinez-Zaguilan R; Perona R; Gillies RJ
J Cell Physiol; 1994 Jun; 159(3):551-60. PubMed ID: 8188769
[TBL] [Abstract][Full Text] [Related]
6. Signaling-competent receptor chimeras allow mapping of major insulin receptor binding domain determinants.
Schumacher R; Soos MA; Schlessinger J; Brandenburg D; Siddle K; Ullrich A
J Biol Chem; 1993 Jan; 268(2):1087-94. PubMed ID: 7678247
[TBL] [Abstract][Full Text] [Related]
7. Insulin action and glucose metabolism in nondiabetic control and NIDDM subjects. Comparison using human skeletal muscle cell cultures.
Henry RR; Abrams L; Nikoulina S; Ciaraldi TP
Diabetes; 1995 Aug; 44(8):936-46. PubMed ID: 7622000
[TBL] [Abstract][Full Text] [Related]
8. The carboxy terminal 110 amino acid portion of the insulin receptor is important for insulin signalling to pyruvate dehydrogenase.
Gottschalk WK; Lammers R; Ullrich A
Biochem Biophys Res Commun; 1992 Dec; 189(2):906-11. PubMed ID: 1472063
[TBL] [Abstract][Full Text] [Related]
9. The bioactivity of insulin analogues from in vitro receptor binding to in vivo glucose uptake.
Drejer K
Diabetes Metab Rev; 1992 Oct; 8(3):259-85. PubMed ID: 1338040
[No Abstract] [Full Text] [Related]
10. Immunological studies of type I IGF receptors and insulin receptors: characterisation of hybrid and atypical receptor subtypes.
Soos MA; Navé BT; Siddle K
Adv Exp Med Biol; 1993; 343():145-57. PubMed ID: 7514333
[No Abstract] [Full Text] [Related]
11. Insulin and IGF-I analogs: novel approaches to improved insulin pharmacokinetics.
Slieker LJ; Brooke GS; Chance RE; Fan L; Hoffmann JA; Howey DC; Long HB; Mayer J; Shields JE; Sundell KL
Adv Exp Med Biol; 1993; 343():25-32. PubMed ID: 8184740
[No Abstract] [Full Text] [Related]
12. Mechanisms whereby insulin and other hormones binding to cell surface receptors influence metabolic pathways within the inner membrane of mitochondria.
Denton RM; McCormack JG; Thomas AP
Ann N Y Acad Sci; 1986; 488():370-84. PubMed ID: 3034119
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
